ISTH 2020 Congress

M.S. López^1,2, J. Paiva³, A.I. Woods⁴, M.S. Saez^1,2, L.H. Barrera^1,5, V. Privitera⁶, F. Chuliber⁶, M. Villagra Iturre⁶, D. Penchasky⁶, P. Sorroche^1,2, J. Oyhamburu^1,2, M. Martinuzzo^1,2, A. Sánchez Luceros^3,4

Abstract Number: PB1582

Degradation of High Molecular Weight von Willebrand Factor Multimers during Extracorporeal Membrane Oxygenation-Treatment

M.-S. Kim¹, C.-J. Park¹, S. Jang¹, Y.-U. Cho¹, S.-B. Hong²

Abstract Number: PB1579

Desmopressin in Patients with Type 2B von Willebrand Disease: Differential Impact on VWF and Platelet Function

A. Dupont^1,2, A. Rauch^1,2, C. Paris^1,2, F. Lassalle^1,2, A. Hochart^1,2, B. Wibaut^1,2, A. Bauters^1,2, J. Goudemand^1,2, C. Zawadzki^1,2, E. Jeanpierre^1,2, S. Susen^1,2

Abstract Number: PB1590

Diagnosis and Management of von Willebrand Disease in a Portuguese Reference Center of Congenital Coagulopathies

C. Catarino Oliveira¹, F. Rodrigues¹, A. Pereira¹, S. Campaniço¹, M. Teodoro¹, C. Silva Pinto², P. Martinho², T. Fidalgo²

Abstract Number: PB1589

Diagnostic Performances Evaluation of LIAPHEN vWF: Ag on CS-2500

C. Dunois¹, P. Gueret², R. Parage², A. Pontis², F. Nedelec², I. Gouin², J. Amiral¹

Abstract Number: PB1574

Establishing Reference Intervals for von Willebrand Factor Multimers

M. Pikta^1,2, M. Vasse³, S. Lejniece^4,5, K.J. Smock^6,7, K.A. Moser^6,7, H. Bautista⁸, G. Nouadje⁸, V. Banys⁹

Abstract Number: PB1565

Evaluation of Carriers of Type 3 von Willebrand Disease with PFA200

T. Geevar¹, R. Gautam Dave¹, S. Singh¹, R. V¹, F. N A², A. Srivastava², S. C Nair¹

Abstract Number: PB1572

Gastrointestinal Bleeding from Angiodysplasia in Constitutional von Willebrand Disease: Improved Diagnosis Yield and Risk Stratification when Using Video Capsule on Top of Conventional Endoscopy

A. Rauch^1,2, C. Paris¹, Y. Repesse³, J. Branche⁴, R. Gerard⁴, R. D'Oiron⁵, A. Harroche⁶, C. Ternisien⁷, S. Castet⁸, A. Lebreton⁹, B. Pan-Petesch¹⁰, F. Volot¹¹, S. Clayssens¹², P. Chamouni¹³, V. Gay¹⁴, A. Veyradier¹⁵, J. Goudemand¹, S. Susen^1,2

Abstract Number: OC 13.2

Genetic Analyses in 391 VWD Patients: Novel VWF Gene Variations, and Important Differences in the Phenotype of Type 1 VWD Patients with- and without – a VWF Gene Mutation

F. Atiq¹, W.L. van Heerde², J. Boender¹, M.H. Cnossen³, B.A.P. Laros-van Gorkom², J. de Meris⁴, K. Fijnvandraat^5,6, S. Schoormans², J.G. van der Bom^7,8, K. Meijer⁹, K.P.M. van Galen¹⁰, J. Eikenboom^11,12, F.W.G. Leebeek¹, WiN Study Group

Abstract Number: PB1595

ISTH 2020 Congress

Platelet Disorders and von Willebrand Disease » VWF and von Willebrand Factor Disorders - Clinical Conditions

A Retrospective Study to Evaluate the Efficacy and Safety of a Plasma-Derived, von Willebrand Factor-Containing FVIII Concentrate, in Patients with Von Willebrand Disease (VWD) in Spain: Interim Analysis Results

Acquired von-Willebrand-Disease (aVWD) in ECMO Patients: a 3-Year Cohort Study

Adolescent Menorrhagia and Von Willebrand Disease

Characterization of Type 2B VWD in the US Zimmerman Program

Clinical and Phenotypic Evaluation of Patients with Low von Willebrand Factor

Clinical Presentation of Von Willebrand Disease in a Developing Country-A Cross Sectional Study

Clinically Relevant Differences between Two New Generation VWF: GPIbR Assays in a Patient with Acquired von Willebrand Syndrome – Case Report

Comparison of von Willebrand Factor (VWF) Multimeric Profile Obtained by a Commercial Electrophoretic Test (Hydragel 5 von Willebrand Multimers) and Classical Home-made with a Discontinuous 1% Agarose Gel Electrophoresis

Degradation of High Molecular Weight von Willebrand Factor Multimers during Extracorporeal Membrane Oxygenation-Treatment

Desmopressin in Patients with Type 2B von Willebrand Disease: Differential Impact on VWF and Platelet Function

Diagnosis and Management of von Willebrand Disease in a Portuguese Reference Center of Congenital Coagulopathies

Diagnostic Performances Evaluation of LIAPHEN vWF: Ag on CS-2500

Establishing Reference Intervals for von Willebrand Factor Multimers

Evaluation of Carriers of Type 3 von Willebrand Disease with PFA200

Gastrointestinal Bleeding from Angiodysplasia in Constitutional von Willebrand Disease: Improved Diagnosis Yield and Risk Stratification when Using Video Capsule on Top of Conventional Endoscopy

Genetic Analyses in 391 VWD Patients: Novel VWF Gene Variations, and Important Differences in the Phenotype of Type 1 VWD Patients with- and without – a VWF Gene Mutation

Gum Bleeding in Low Von Willebrand Factor- What’s the Score?

Gynaecological Problems, Management and Outcomes in Women with Moderate and Severe von Willebrand Disease (VWD)

Harnessing Social Media to Improve Awareness of Bleeding Disorders

High Variability of Laboratory Phenotype in Genetically Proven von Willebrand Disease Type 2B